Primerica, Inc. (PRI) stock analysis
Close on Nov 11, 2026Market cap $9.10BP/E 11.7Yield 1.41%
StockData Score
Prices as of Nov 11, 2026How the score works
Weak5 of 30 checks passed
Primerica passes 5 of the 30 checks behind our score; 17 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 2/6
- Past performance
- 0/6
- Financial health
- 0/6
- Dividend
- 2/6
What stands out
EPS growing 10%+ a year
Diluted EPS grew 22.9% a year over the last three fiscal years.
P/E below its 5-year median
Primerica's P/E of 11.7 is below its own 5-year median of 13.0.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Growing faster than the industry
Revenue grew 8.3% over the last twelve months; the Life Insurance median is 7.1%.
What to watch
Margin of safety under 20%
The price is 13.7% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $295.61 is above our fair value estimate of $260.09.
Revenue growing under 10% a year
Revenue grew 7.4% a year over the last three fiscal years, short of the 10% we look for.
P/E above the industry
Primerica's P/E of 11.7 is above the Life Insurance median of 10.8.
Valuation1/6
P/E below its 5-year median
Primerica's P/E of 11.7 is below its own 5-year median of 13.0.
P/E above the industry
Primerica's P/E of 11.7 is above the Life Insurance median of 10.8.
P/S above the industry
Primerica's price-to-sales of 2.60 is above the Life Insurance median of 0.67.
P/B above the industry
Primerica's price-to-book of 3.22 is above the Life Insurance median of 1.11.
Trading above fair value
The share price of $295.61 is above our fair value estimate of $260.09.
Margin of safety under 20%
The price is 13.7% above fair value, so there is no margin of safety.
Growth2/6
Revenue growing under 10% a year
Revenue grew 7.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 22.9% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 8.3% over the last twelve months; the Life Insurance median is 7.1%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance0/6
Return on equity
Needs positive equity and five years of results.
Return on assets
Needs net income and total assets.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend2/6
Pays a dividend
Primerica paid dividends worth 1.6% of the share price over the last twelve months.
Yield below Treasuries
The 1.6% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Primerica yields 1.6%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Earnings cover
Needs dividends paid and net income.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$260.09
The share price is 14% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 11.9× | 13.0× | 10.8× | $302.26 | 50% |
| P/B | 2.4× | 3.6× | 1.1× | $217.92 | 50% |
| Fair value | $260.09 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 13.0
- Life Insurance median 10.8
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $57.07M
- Value traded per 1% price move
- $54.45M
Downside
Low risk
- Typical loss in a bad month
- 8.7%
- Volatility (annualized)
- 21%
- Sharpe ratio, 1 year
- 0.55
- Beta to the S&P 500 (5Y)
- 0.77
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.6% | +7.4% | +8.2% | +8.9% | |
| EPS, diluted | +67.1% | +22.9% | +19.1% | +20.0% | |
| Dividend per share | +26.1% | +23.7% | +21.1% | +20.6% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 18.5% | 22.1% | – | |
| Return on assets | 2.0% | 2.7% | – | |
| Diluted shares | 47M | 40M | 33M |
Cash use needs five years of cash flow figures
Primerica does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2024 | 15.2% | 0.21× | 6.85× | 21.8% |
| FY2023 | 21.0% | 0.19× | 7.24× | 28.1% |
| FY2022 | 17.8% | 0.17× | 10.43× | 31.9% |
| FY2021 | 17.6% | 0.17× | 11.26× | 34.6% |
| FY2020 | 17.4% | 0.16× | 8.20× | 22.1% |
| FY2019 | 17.9% | 0.16× | 8.44× | 23.5% |
| FY2018 | 17.1% | 0.15× | 8.70× | 22.5% |
| FY2017 | 20.7% | 0.14× | 9.05× | 26.5% |
| FY2016 | 14.4% | 0.14× | 9.31× | 18.5% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$901.18M
- Return on assets improvedROA up on the prior year3.1% → –
- Earnings backed by cashOperating cash flow above net income$901.18M vs –
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise34M → 33M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.21 → 0.23
See a number that looks wrong?